Literature DB >> 1060788

Effects of prostaglandin F2alpha on the oestrous cycle and pregnancy in mares.

R H Douglas, O J Ginther.   

Abstract

Several experiments indicated that prostaglandin F2alpha (PGF2alpha) has luteolytic and abortifacient properties in mares. A single subcutaneous injection of 1-25 mg PGF2alpha on Day 6 of dioestrus was as effective as 10 mg PGF2alpha in inducing luteolysis. Oestrus and ovulation appeared to be synchronized when a single injection of 1-25 mg PGF2alpha was given on Days 7, 10 or 13 after ovulation but not on Days 1 or 4 after ovulation or on Day 2 of oestrus. Intramuscular administration was as effective as subcutaneous administration and 1-25 mg PGF2alpha was the minimal effective systemic dose to induce luteolysis. Administration of PGF2alpha into the uterus or directly into the CL did not improve the luteolytic efficacy of the intramuscular injection of PGF2alpha. All thirteen mares aborted following injections of 2-5 mg PGF2alpha at 12-hr intervals; an average of 3-7 injections were given before abortion occurred.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1060788

Source DB:  PubMed          Journal:  J Reprod Fertil Suppl        ISSN: 0449-3087


  3 in total

1.  Prostaglandin F2alpha treatment of cyclic dysfunction in mares.

Authors:  D Mitchell; R de Gannes; E A Sugden
Journal:  Can Vet J       Date:  1976-12       Impact factor: 1.008

2.  Evidence for a dopamine intrinsic direct role in the regulation of the ovary reproductive function: in vitro study on rabbit corpora lutea.

Authors:  Francesco Parillo; Margherita Maranesi; Fiorenzo Mignini; Lisa Marinelli; Antonio Di Stefano; Cristiano Boiti; Massimo Zerani
Journal:  PLoS One       Date:  2014-08-22       Impact factor: 3.240

3.  Kisspeptin/kisspeptin receptor system in pseudopregnant rabbit corpora lutea: presence and function.

Authors:  Margherita Maranesi; Linda Petrucci; Leonardo Leonardi; Antonello Bufalari; Francesco Parillo; Cristiano Boiti; Massimo Zerani
Journal:  Sci Rep       Date:  2019-03-25       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.